108 related articles for article (PubMed ID: 713278)
21. The effect of lowering the serum phosphate on parathyroid hormone secretion and total serum calcium during regular hemodialysis.
Hill AV; Thein-Than ; Cook DB; Derr KN; Latner AL
Clin Nephrol; 1973; 1(5):284-9. PubMed ID: 4797465
[No Abstract] [Full Text] [Related]
22. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH).
Roof BS; Piel CF; Gordan GS
Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621
[No Abstract] [Full Text] [Related]
23. Effect of dialysate calcium concentration on plasma parathyroid hormone during hemodialysis.
McIntosh CH; Fuchs C; Dorn D; Quellhorst E; Henning HV; Hesch RD; Scheler F
Nephron; 1977; 19(2):88-94. PubMed ID: 887190
[TBL] [Abstract][Full Text] [Related]
24. [Is there a relation between parathormone and prolactin secretion in patients with acute and chronic kidney failure?].
Kokot F; Grzeszczak W; Duława J
Z Gesamte Inn Med; 1984 Feb; 39(3):40-3. PubMed ID: 6711067
[TBL] [Abstract][Full Text] [Related]
25. Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study.
Zehnder D; Landray MJ; Wheeler DC; Fraser W; Blackwell L; Nuttall S; Hughes SV; Townend J; Ferro C; Baigent C; Hewison M
Nephron Clin Pract; 2007; 107(3):c109-16. PubMed ID: 17890873
[TBL] [Abstract][Full Text] [Related]
26. Effect of fluoride therapy on nondialyzable urinary hydroxyproline, serum alkaline phosphatase, parathyroid hormone, and 25-hydroxyvitamin D.
Manzke E; Rawley R; Vose G; Roginsky M; Rader JI; Baylink DJ
Metabolism; 1977 Sep; 26(9):1005-10. PubMed ID: 895531
[No Abstract] [Full Text] [Related]
27. [Effect of 1-alpha-hydroxyvitamin D-3 on calcium concentration and the level of immunoreactive parathormone in the serum of patients with chronic renal failure].
Pietrek J; Kokot F; Kuska J
Pol Arch Med Wewn; 1977 Nov; 58(5):471-9. PubMed ID: 600825
[No Abstract] [Full Text] [Related]
28. The CARI guidelines. Management of bone disease, calcium, phosphate and parathyroid hormone.
Elder G; Faull R; Branley P; Hawley C;
Nephrology (Carlton); 2006 Apr; 11 Suppl 1():S230-61. PubMed ID: 16684078
[No Abstract] [Full Text] [Related]
29. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
Fournier A; Bordier P; Gueris J; Sebert JL; Marie P; Ferrière C; Bedrossian J; DeLuca HF
Kidney Int; 1979 Feb; 15(2):196-204. PubMed ID: 513484
[No Abstract] [Full Text] [Related]
30. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
[TBL] [Abstract][Full Text] [Related]
31. Vitamin-D deficiency among Asian immigrants to Britain.
Preece MA; McIntosh WB; Tomlinson S; Ford JA; Dunnigan MG; O'Riordan JL
Lancet; 1973 Apr; 1(7809):907-10. PubMed ID: 4123837
[No Abstract] [Full Text] [Related]
32. Effects of 1,25-dihydroxycholecalciferol on serum calcium, phosphate, and immunoreactive parathyroid hormone in dogs.
Oldham SB; Smith R; Hartenbower DL; Henry HL
Adv Exp Med Biol; 1978; 103():509-16. PubMed ID: 717120
[No Abstract] [Full Text] [Related]
33. Failure to show a correlation between serum parathyroid hormone, nerve conduction velocity and serum lipids in hemodialysis patients.
Schaefer K; Offermann G; von Herrath D; Schröter R; Stölzel R; Arntz HR
Clin Nephrol; 1980 Aug; 14(2):81-8. PubMed ID: 7408260
[TBL] [Abstract][Full Text] [Related]
34. Blood levels of 25-hydroxyvitamin D in nephrotic syndrome. Studies in 26 patients.
Goldstein DA; Oda Y; Kurokawa K; Massry SG
Ann Intern Med; 1977 Dec; 87(6):664-7. PubMed ID: 931202
[TBL] [Abstract][Full Text] [Related]
35. Effects on serum parathyroid hormone of intravenous treatment with alphacalcidol in patients on chronic hemodialysis.
Ljunghall S; Althoff P; Fellström B; Marjanovic B; Nisell J; Weiss L; Wide L
Nephron; 1990; 55(4):380-5. PubMed ID: 2392190
[TBL] [Abstract][Full Text] [Related]
36. Serum parathyroid hormone concentration in chronic renal failure patients on maintenance haemodialysis.
Wills MR; Fairney A; Varghese Z; Tatler GL; Baillod RA; Moorhead JF
Clin Chim Acta; 1974 Nov; 57(1):83-9. PubMed ID: 4430145
[No Abstract] [Full Text] [Related]
37. Hypercalcaemia in idiopathic rhabdomyolysis.
Fuss M; Dupont E; Brauman H; Corvilain J
Lancet; 1977 Feb; 1(8008):429-30. PubMed ID: 65543
[No Abstract] [Full Text] [Related]
38. Suppressive effect of 1,25-dihydroxyvitamin D3 on circulating parathyroid hormone in acute renal failure.
Madsen S; Olgaard K; Ladefoged J
J Clin Endocrinol Metab; 1981 Oct; 53(4):823-7. PubMed ID: 6895227
[TBL] [Abstract][Full Text] [Related]
39. [Secondary hyperparathyroidism in patients with chronic kidney failure].
Fillastre JP; Robert M; Dubois D
Sem Hop; 1973 Feb; 49(7):501-6. PubMed ID: 4350601
[No Abstract] [Full Text] [Related]
40. Alterations in calcium, phosphorus and C-terminal parathyroid hormone levels in equine acute renal disease.
Elfers RS; Bayly WM; Brobst DF; Reed SM; Liggitt HD; Hawker CD; Baylink DJ
Cornell Vet; 1986 Jul; 76(3):317-29. PubMed ID: 3731786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
